Utama › Penyakit Paru-paru › New York › New York City
Kajian klinikal Penyakit Paru-paru di New York City, NY
12 kajian untuk Penyakit Paru-paru sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Mengambil pesertaFasa 3
- Research Site, New York
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Mengambil pesertaFasa 3
- NYU Langone's Perlmutter Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
American Lung Association (ALA) Lung Health Cohort
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mt. Sinai, NYC, New York
- Columbia University, New York
- Cornell University, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Laura and Isaac Perlmutter Cancer Center, New York
- Manhattan Eye, Ear and Throat Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Mengambil pesertaFasa 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Mengambil pesertaFasa 2
- Mount Sinai, Icahn School of Medicine, New York
- Columbia University, New York
- Cornell University, New York
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Mengambil pesertaFasa 2
- New York University Langone Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Mengambil pesertaFasa 1/2
- Weill Medical College of Cornell University, New York
- Memorial Sloan Kettering Cancer Center, New York
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine, New York
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Mengambil peserta
- Cornell University, New York
- University of Rochester, New York
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Mengambil pesertaFasa 3
- Memorial Sloan Kettering Cancer Center, New York
Kajian Penyakit Paru-paru di bandar lain
- Houston, TX15 kajian
- Boston, MA14 kajian
- Durham, NC13 kajian
- Pittsburgh, PA11 kajian
- Miami, FL10 kajian
- Dallas, TX10 kajian
- Columbus, OH10 kajian
- Nashville, TN10 kajian
- Los Angeles, CA10 kajian
- Washington, DC10 kajian
- Ann Arbor, MI10 kajian
- Birmingham, AL9 kajian
Kajian lain di New York City
- Kanser Payudara136 kajian
- Kanser Paru-paru Bukan Sel Kecil121 kajian
- Kanser (semua jenis)109 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal78 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Pankreas60 kajian
- Kanser Endometrium52 kajian
- Leukemia Mieloid Akut51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.